MarketCap
Facebook
X
TelegramАптеки 36.6 Finanzdaten 2004-2025 | APTK
Schlüsselkennzahlen Аптеки 36.6
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow Per Share |
0.864 | 0.423 | -0.495 | -0.358 | -3.87 | -4.22 | -3.04 | 3.59 | -0.327 | -28.8 | 6.42 | -0.008 | -16.1 | -0.487 | 0.078 | -0.163 | -131 | -42.4 | 19 |
Free Cash Flow Per Share |
0.729 | 0.294 | -0.777 | -0.764 | -4.21 | -4.4 | -3.43 | -0.713 | -1.03 | -29.6 | -4.35 | -7.12 | -19.4 | -0.529 | -0.007 | -0.362 | -225 | -103 | -19.3 |
Cash Per Share |
0.106 | 0.226 | -0.06 | 0.17 | 0.212 | 0.25 | 0.51 | 0.268 | 0.36 | 3.88 | 6.65 | 9.28 | 8.53 | 0.151 | 0.145 | 0.165 | 37.7 | 25 | 5.09 |
Price To Sales Ratio |
1.5 | 2.4 | 2.44 | 1.33 | 0.27 | 0.475 | 0.257 | 0.528 | 0.729 | 0.206 | 0.194 | 0.226 | 0.279 | 11 | 7.55 | 11.2 | 0.03 | 0.05 | 0.071 |
Dividend Yield |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Payout Ratio |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue Per Share |
7.74 | 5.78 | 5.77 | 9.24 | 18.8 | 18.3 | 40.1 | 30.1 | 17.5 | 94.5 | 166 | 171 | 170 | 4.31 | 6.29 | 4.25 | 1.59 K | 954 | 669 |
Net Income Per Share |
0.029 | -0.125 | -0.146 | -1.78 | -9.67 | -4.97 | -8.15 | -0.168 | -0.106 | -82.5 | -7.71 | -8.21 | -7.76 | -0.074 | -0.341 | -0.61 | 104 | 25.9 | 3.51 |
Book Value Per Share |
-0.843 | -0.872 | -0.838 | -4.73 | -15.5 | -5.24 | -0.463 | 1.31 | 0.222 | -84.4 | 29.2 | 33.3 | 40.2 | 0.918 | 1.01 | 1.14 | 385 | 201 | 135 |
Tangible Book Value Per Share |
-2.61 | -2.56 | -2.67 | -6.66 | -21.7 | -17 | -34.9 | -23.1 | -10.5 | -84.6 | -12.9 | -8.14 | -3.16 | -0.139 | -0.065 | -0.163 | -110 | 84.9 | 59.2 |
Shareholders Equity Per Share |
-0.843 | -0.872 | -0.838 | -4.73 | -15.5 | -5.24 | -0.463 | 1.31 | -0.68 | -84.8 | 1.7 | 9.48 | 18 | 0.446 | 0.054 | 0.381 | 257 | 154 | 128 |
Interest Debt Per Share |
4.81 | 4.1 | 7.98 | 9.22 | 25.9 | 13.5 | 19.9 | 14.4 | 12.7 | 79.6 | 98.3 | 87.4 | 116 | 1.77 | 1.13 | 1.68 | 787 | 396 | 272 |
Market Cap |
88.3 B | 106 B | 95.6 B | 61.2 B | 12.1 B | 22.9 B | 11.8 B | 16.8 B | 13.9 B | 2.45 B | 4.05 B | 4.87 B | 5.69 B | 232 B | 232 B | 232 B | 430 M | 430 M | 430 M |
Enterprise Value |
120 B | 136 B | 144 B | 101 B | 66.8 B | 54.4 B | 31.5 B | 29.8 B | 26 B | 10.5 B | 14.1 B | 13.6 B | 17.3 B | 239 B | 236 B | 238 B | 6.75 B | 3.36 B | 2.61 B |
P/E Ratio |
396 | -112 | -96.4 | -6.91 | -0.526 | -1.75 | -1.26 | -94.7 | -121 | -0.236 | -4.18 | -4.71 | -6.12 | -645 | -139 | -77.8 | 0.458 | 1.83 | 13.5 |
P/OCF Ratio |
13.4 | 32.9 | -28.4 | -34.3 | -1.31 | -2.06 | -3.39 | 4.43 | -39.1 | -0.677 | 5.01 | -4.87 K | -2.95 | -97.6 | 613 | -291 | -0.361 | -1.12 | 2.5 |
P/FCF Ratio |
15.9 | 47.2 | -18.1 | -16.1 | -1.21 | -1.98 | -3.01 | -22.3 | -12.4 | -0.659 | -7.4 | -5.43 | -2.45 | -89.7 | -6.87 K | -131 | -0.211 | -0.459 | -2.46 |
P/B Ratio |
-13.7 | -15.9 | -16.8 | -2.6 | -0.328 | -1.66 | -22.3 | 12.1 | -18.8 | -0.23 | 18.9 | 4.08 | 2.63 | 107 | 884 | 125 | 0.185 | 0.309 | 0.372 |
EV/Sales |
2.03 | 3.08 | 3.68 | 2.19 | 1.5 | 1.13 | 0.686 | 0.934 | 1.36 | 0.883 | 0.675 | 0.628 | 0.85 | 11.3 | 7.67 | 11.5 | 0.47 | 0.389 | 0.432 |
EV/EBITDA |
11.5 | 63.7 | 14.8 | 82.7 | -6.67 | -7.34 | -5.84 | 726 | 28.8 | -1.29 | 4.74 | 6.8 | 9.96 | 132 | 496 | -281 | 3.05 | 3.26 | 4.8 |
EV/OCF |
18.2 | 42 | -42.9 | -56.6 | -7.26 | -4.89 | -9.05 | 7.82 | -72.9 | -2.9 | 17.5 | -13.6 K | -8.98 | -100 | 623 | -299 | -5.68 | -8.76 | 15.2 |
Earnings Yield |
0.003 | -0.009 | -0.01 | -0.145 | -1.9 | -0.572 | -0.791 | -0.011 | -0.008 | -4.24 | -0.24 | -0.212 | -0.163 | -0.002 | -0.007 | -0.013 | 2.18 | 0.546 | 0.074 |
Free Cash Flow Yield |
0.063 | 0.021 | -0.055 | -0.062 | -0.83 | -0.506 | -0.332 | -0.045 | -0.081 | -1.52 | -0.135 | -0.184 | -0.408 | -0.011 | -0.0 | -0.008 | -4.73 | -2.18 | -0.406 |
Debt To Equity |
-5.05 | -4.71 | -8.72 | -1.72 | -1.5 | -2.33 | -38.2 | 9.52 | -16.8 | -0.8 | 51 | 8.01 | 5.86 | 3.43 | 17 | 3.89 | 2.86 | 2.27 | 1.93 |
Debt To Assets |
0.744 | 0.828 | 0.913 | 1.24 | 1.69 | 0.806 | 0.453 | 0.484 | 0.383 | 2.25 | 0.491 | 0.438 | 0.674 | 0.433 | 0.258 | 0.364 | 0.482 | 0.449 | 0.471 |
Net Debt To EBITDA |
3.03 | 13.9 | 5.01 | 32.6 | -5.46 | -4.25 | -3.65 | 315 | 13.4 | -0.986 | 3.38 | 4.36 | 6.69 | 3.72 | 7.91 | -7.58 | 2.86 | 2.84 | 4.01 |
Current Ratio |
0.537 | 0.467 | 1.23 | 0.543 | 0.3 | 0.627 | 0.471 | 0.702 | 0.768 | 0.335 | 0.815 | 0.821 | 1.32 | 1.12 | 0.76 | 0.649 | 1.2 | 1.29 | 0.639 |
Interest Coverage |
1.13 | - | 0.171 | -0.151 | -0.64 | -1.07 | -2.06 | -0.189 | 0.636 | -5.28 | 1.58 | 1.24 | 1.0 | 0.75 | -0.374 | -1.47 | 0.743 | 0.996 | 1.41 |
Income Quality |
16 | -2.24 | -0.497 | 0.204 | 0.4 | 0.85 | 0.373 | -21.4 | 0.615 | 0.367 | 0.741 | 0.043 | 48.2 | -15.3 | -0.589 | 0.331 | -1.27 | -1.63 | 5.41 |
Sales General And Administrative To Revenue |
0.019 | 0.323 | 0.006 | 0.01 | 0.011 | 0.006 | 0.003 | 0.005 | 0.007 | 0.026 | 0.003 | 0.366 | 0.351 | 0.35 | 0.335 | 0.36 | - | - | - |
Intangibles To Total Assets |
0.309 | 0.34 | 0.23 | 0.295 | 0.45 | 0.778 | 0.881 | 0.945 | 0.359 | 0.004 | 0.238 | 0.239 | 0.277 | 0.299 | 0.303 | 0.32 | 0.324 | 0.149 | 0.146 |
Capex To Operating Cash Flow |
0.157 | 0.304 | -0.571 | -1.13 | -0.089 | -0.041 | -0.128 | 1.2 | -2.16 | -0.026 | 1.68 | -896 | -0.203 | -0.088 | 1.09 | -1.22 | -0.711 | -1.44 | 2.02 |
Capex To Revenue |
0.018 | 0.022 | 0.049 | 0.044 | 0.018 | 0.01 | 0.01 | 0.143 | 0.04 | 0.008 | 0.065 | 0.041 | 0.019 | 0.01 | 0.013 | 0.047 | 0.059 | 0.064 | 0.057 |
Capex To Depreciation |
0.179 | 0.169 | 0.36 | 0.392 | 0.15 | 0.307 | 0.428 | 10.8 | 4.71 | 0.419 | 3.36 | 1.96 | 0.82 | 0.435 | 0.651 | 1.95 | 2.41 | 2.51 | 1.72 |
Stock Based Compensation To Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.001 | 0.003 | - | - | - |
Graham Number |
0.744 | 1.56 | 1.66 | 13.8 | 58 | 24.2 | 9.22 | 2.23 | 1.27 | 397 | 17.2 | 41.8 | 56.1 | 0.859 | 0.642 | 2.29 | 774 | 299 | 100 |
Return On Invested Capital, ROIC |
0.099 | 0.027 | 0.028 | -0.047 | -0.219 | -0.203 | -0.252 | -0.022 | 0.022 | 3.91 | 0.126 | 1.54 | 0.97 | 0.012 | -0.052 | -0.118 | 0.027 | 0.055 | 0.023 |
Return On Tangible Assets, ROTA |
0.007 | -0.038 | -0.024 | -0.385 | -1.28 | -1.48 | -1.76 | -0.118 | -0.006 | -2.75 | -0.057 | -0.062 | -0.068 | -0.03 | -0.138 | -0.22 | 0.1 | 0.039 | 0.008 |
Graham Net Net |
-5.89 | -4.7 | -8.51 | -10 | -27.1 | -17.5 | -34.3 | -21 | -20.9 | -102 | -85.1 | -67 | -91.3 | -1.39 | -1.31 | -2.34 | -695 | -325 | -246 |
Working Capital |
-12.7 B | -15.4 B | 5.76 B | -12 B | -25.7 B | -9.37 B | -14.8 B | -3.93 B | -5.59 B | -5.29 B | -2.93 B | -2.83 B | 2.53 B | 958 M | -2.75 B | -4.81 B | 1.07 B | 779 M | -1.11 B |
Tangible Asset Value |
-19.9 B | -19.5 B | -18.2 B | -33.2 B | -51.5 B | -44.9 B | -40 B | -24.4 B | -11.5 B | -10.7 B | -1.62 B | -1.03 B | -378 M | -677 M | -316 M | -797 M | -1 B | 768 M | 535 M |
Net Current Asset Value, NCAV |
-35.3 B | -31 B | -29.8 B | -41.9 B | -58.5 B | -38 B | -32.2 B | -16.7 B | -13.9 B | -11.8 B | -5.66 B | -4.65 B | -3.45 B | -3.89 B | -3.69 B | -5.45 B | -4.06 B | -1.78 B | -1.54 B |
Invested Capital |
15.4 B | 8.38 B | 29.5 B | 6.15 B | -10.5 B | 22.5 B | 25.7 B | 22.9 B | 7.69 B | -4.25 B | 6.14 B | 5.69 B | 10.6 B | 9.13 B | 5.84 B | 6.16 B | 8.61 B | 4.26 B | 1.66 B |
Average Receivables |
2.45 B | 2.45 B | 1.13 B | 1.9 B | 2.77 B | 3.04 B | 1.84 B | 3.72 B | 3.09 B | 3.71 B | 7.82 B | 4.28 B | 2.35 B | 4.75 B | 2.4 B | 1.48 B | 2.37 B | 1.43 B | - |
Average Payables |
12.8 B | 9.55 B | 10.6 B | 12.2 B | 14.8 B | 19.9 B | 16.3 B | 14.2 B | 10.6 B | 4.91 B | 5.63 B | 4.34 B | 3.58 B | 4.95 B | 5.5 B | 3.94 B | 2.23 B | 1.17 B | - |
Average Inventory |
7.49 B | 5.82 B | 6.39 B | 7.32 B | 7.45 B | 7.78 B | 6.12 B | 6.99 B | 5.6 B | 2.55 B | 3.34 B | 3.65 B | 3.73 B | 3.39 B | 3.78 B | 3.61 B | 2.2 B | 1.13 B | - |
Days Sales Outstanding |
- | 40.6 | - | 18 | 12.5 | 30.4 | 16.4 | 18.3 | 112 | 10.3 | 124 | 145 | - | 81.4 | 57.1 | - | 75.4 | 75.1 | 65 |
Days Payables Outstanding |
138 | 138 | 115 | 145 | 106 | 178 | 217 | 174 | 467 | 161 | 161 | 164 | 101 | 110 | 110 | 123 | 115 | 104 | 80.3 |
Days Of Inventory On Hand |
80.6 | 80.2 | 74.3 | 83.6 | 66.6 | 76.3 | 78 | 71.1 | 255 | 69.8 | 92.8 | 101 | 122 | 98.8 | 60.2 | 106 | 116 | 98.3 | 82.3 |
Receivables Turnover |
- | 8.99 | - | 20.3 | 29.2 | 12 | 22.2 | 19.9 | 3.26 | 35.3 | 2.96 | 2.52 | - | 4.48 | 6.39 | - | 4.84 | 4.86 | 5.61 |
Payables Turnover |
2.65 | 2.64 | 3.18 | 2.52 | 3.44 | 2.05 | 1.68 | 2.1 | 0.781 | 2.27 | 2.27 | 2.22 | 3.61 | 3.32 | 3.32 | 2.96 | 3.18 | 3.51 | 4.54 |
Inventory Turnover |
4.53 | 4.55 | 4.91 | 4.36 | 5.48 | 4.79 | 4.68 | 5.13 | 1.43 | 5.23 | 3.93 | 3.62 | 2.99 | 3.69 | 6.06 | 3.44 | 3.16 | 3.71 | 4.43 |
Return On Equity, ROE |
-0.035 | 0.143 | 0.174 | 0.376 | 0.624 | 0.948 | 17.6 | -0.128 | 0.155 | 0.974 | -4.54 | -0.865 | -0.431 | -0.165 | -6.35 | -1.6 | 0.403 | 0.169 | 0.027 |
Capex Per Share |
0.136 | 0.129 | 0.282 | 0.406 | 0.346 | 0.174 | 0.389 | 4.31 | 0.705 | 0.762 | 10.8 | 7.11 | 3.27 | 0.043 | 0.084 | 0.199 | 93.4 | 61 | 38.3 |
Alle Zahlen in RUB-Währung
Schlüsselkennzahlen Vierteljährlich Аптеки 36.6
| 2023-Q2 | 2022-Q4 | 2021-Q4 | 2021-Q2 | 2020-Q4 | 2020-Q2 | 2019-Q4 | 2019-Q2 | 2018-Q4 | 2018-Q2 | 2017-Q4 | 2017-Q2 | 2016-Q4 | 2016-Q2 | 2015-Q4 | 2015-Q2 | 2014-Q4 | 2014-Q2 | 2013-Q4 | 2013-Q2 | 2012-Q4 | 2012-Q2 | 2011-Q4 | 2010-Q4 | 2010-Q2 | 2009-Q4 | 2009-Q2 | 2008-Q4 | 2008-Q2 | 2007-Q4 | 2007-Q2 | 2006-Q4 | 2006-Q2 | 2005-Q4 | 2005-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow Per Share |
0.0 | - | - | -0.1 | 0.267 | -0.79 | 0.282 | -1.19 | -1.53 | -2.42 | -2.03 | -2.75 | -1.93 | -1.49 | 3.66 | 0.292 | - | -16.3 | -33.1 | 4.27 | 1.52 | - | - | -8.05 | -8.05 | -0.243 | -0.243 | 0.039 | 0.039 | -0.082 | -0.082 | -65.7 | -65.7 | -21.2 | -21.2 |
Free Cash Flow Per Share |
0.0 | - | - | -0.144 | 0.219 | -1.02 | 0.065 | -1.36 | -1.73 | -2.49 | -2.14 | -2.79 | -2.13 | -1.66 | 3.47 | 0.292 | - | -16.4 | -31.8 | 2.26 | -1.0 | - | - | -9.69 | -9.69 | -0.265 | -0.265 | -0.003 | -0.003 | -0.181 | -0.181 | -112 | -112 | -51.7 | -51.7 |
Cash Per Share |
0.068 | - | 0.226 | 0.239 | -0.054 | 0.194 | 0.124 | 0.135 | 0.216 | 0.306 | 0.283 | 0.136 | 0.557 | 0.304 | 0.293 | 0.806 | - | 2.12 | 3.88 | 5.71 | 3.32 | - | - | 8.53 | 7.34 | 0.151 | 0.148 | 0.145 | 0.155 | 0.165 | 0.118 | 37.7 | 31.4 | 25 | 15 |
Price To Sales Ratio |
3.38 | - | 4.56 | 5.1 | 8.39 | 3.69 | 3.34 | 1.7 | 0.537 | 0.609 | 0.792 | 0.937 | 0.466 | 0.501 | 0.976 | 0.827 | - | 0.14 | 0.412 | 0.471 | 0.887 | - | - | 0.558 | 0.558 | 22 | 22 | 15.1 | 15.1 | 22.3 | 22.3 | 0.06 | 0.06 | 0.1 | 0.1 |
Dividend Yield |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Payout Ratio |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue Per Share |
4 | - | 3.05 | 2.73 | 1.67 | 3.87 | 3.68 | 6.69 | 9.47 | 9.7 | 11 | 9.72 | 22.1 | 23.2 | 16.3 | 17.8 | - | 102 | 47.3 | 47.3 | 36.3 | - | - | 85.1 | 85.1 | 2.16 | 2.16 | 3.14 | 3.14 | 2.13 | 2.13 | 794 | 794 | 477 | 477 |
Net Income Per Share |
0.011 | - | 0.045 | -0.169 | 0.032 | -0.348 | -0.744 | -1.21 | -7.49 | -2.37 | -4.55 | -1.06 | -8.93 | 0.034 | -0.451 | 0.287 | - | -3.8 | -41.3 | -41.3 | 0.151 | - | - | -3.88 | -3.88 | -0.037 | -0.037 | -0.171 | -0.171 | -0.305 | -0.305 | 51.8 | 51.8 | 13 | 13 |
Book Value Per Share |
-0.871 | - | -0.872 | -0.917 | -0.748 | -3.79 | -3.44 | -5.92 | -15.8 | -8.1 | -5.93 | 0.011 | -0.505 | 3.93 | 1.43 | 3.46 | - | -106 | -81.8 | 21.8 | 14.6 | - | - | 40.2 | 38.8 | 0.918 | 0.964 | 1.01 | 1.07 | 1.14 | 0.927 | 385 | 293 | 201 | 168 |
Tangible Book Value Per Share |
-2.61 | - | -2.56 | -2.52 | -2.39 | -5.18 | -4.85 | -9.49 | -20.7 | -17.6 | -15.8 | -12.6 | -29 | -13.1 | -15.4 | -13 | - | -106 | -81.9 | -23.3 | -6.44 | - | - | -3.16 | -4.4 | -0.139 | -0.102 | -0.065 | -0.114 | -0.163 | -0.184 | -110 | -12.8 | 84.9 | 72 |
Shareholders Equity Per Share |
-0.871 | - | -0.872 | -0.917 | -0.748 | -3.79 | -3.44 | -5.92 | -15.8 | -8.1 | -5.93 | 0.011 | -0.505 | 3.93 | 1.43 | 2.99 | - | -106 | -82.2 | -7.06 | 0.849 | - | - | 18 | 18.1 | 0.446 | 0.25 | 0.054 | 0.218 | 0.381 | 0.429 | 257 | 205 | 154 | 141 |
Interest Debt Per Share |
4.34 | - | 4.1 | 4.09 | 6.79 | 7.75 | 6.35 | 13.2 | 23.7 | 17 | 13.8 | 11.4 | 19.3 | 16.2 | 13.6 | 11.6 | - | 91.9 | 73.7 | 102 | 43.3 | - | - | 111 | 89.3 | 1.65 | 1.34 | 1.02 | 1.31 | 1.58 | 1.52 | 761 | 568 | 373 | 321 |
Market Cap |
103 B | - | 106 B | 106 B | 107 B | 97.8 B | 84.1 B | 35.5 B | 11.8 B | 13.8 B | 20.3 B | 21.2 B | 10.8 B | 11.4 B | 15.4 B | 13.3 B | - | 1.49 B | 2.45 B | 2.81 B | 8.11 B | - | - | 5.69 B | 5.69 B | 232 B | 232 B | 232 B | 232 B | 232 B | 232 B | 430 M | 430 M | 430 M | 430 M |
Enterprise Value |
136 B | 31.6 B | 136 B | 136 B | 156 B | 147 B | 124 B | 73.9 B | 66.6 B | 52.8 B | 51.8 B | 47.4 B | 30.5 B | 26.9 B | 28.3 B | 23.1 B | 12.1 B | 10.9 B | 10.5 B | 14.2 B | 18.2 B | 9.32 B | 8.68 B | 17.3 B | 14.9 B | 239 B | 237 B | 236 B | 237 B | 238 B | 238 B | 6.75 B | 5.06 B | 3.36 B | 2.99 B |
P/E Ratio |
296 | - | 77.8 | -20.6 | 109 | -10.3 | -4.13 | -2.36 | -0.169 | -0.625 | -0.477 | -2.14 | -0.289 | 86.1 | -8.82 | 12.9 | - | -0.936 | -0.118 | -0.135 | 53.3 | - | - | -3.06 | -3.06 | -323 | -323 | -69.6 | -69.6 | -38.9 | -38.9 | 0.229 | 0.229 | 0.915 | 0.915 |
P/OCF Ratio |
72.3 K | - | - | -140 | 52.7 | -18.1 | 43.6 | -9.56 | -3.32 | -2.44 | -4.29 | -3.31 | -5.34 | -7.82 | 4.35 | 50.4 | - | -0.875 | -0.589 | 5.21 | 21.2 | - | - | -5.9 | -5.9 | -195 | -195 | 1.23 K | 1.23 K | -582 | -582 | -0.723 | -0.723 | -2.24 | -2.24 |
P/FCF Ratio |
99.9 K | - | - | -96.9 | 64.2 | -14.1 | 189 | -8.35 | -2.93 | -2.37 | -4.06 | -3.26 | -4.83 | -7.01 | 4.58 | 50.4 | - | -0.866 | -0.612 | 9.84 | -32.2 | - | - | -4.9 | -4.9 | -179 | -179 | -13.7 K | -13.7 K | -262 | -262 | -0.422 | -0.422 | -0.919 | -0.919 |
P/B Ratio |
-15.5 | - | -15.9 | -15.2 | -18.8 | -3.77 | -3.57 | -1.92 | -0.322 | -0.729 | -1.47 | 817 | -20.4 | 2.96 | 11.1 | 4.94 | - | -0.134 | -0.237 | -3.15 | 37.9 | - | - | 2.63 | 2.62 | 107 | 190 | 884 | 218 | 125 | 111 | 0.185 | 0.231 | 0.309 | 0.338 |
EV/Sales |
4.45 | - | 5.83 | 6.51 | 12.2 | 5.56 | 4.92 | 3.54 | 3.02 | 2.34 | 2.02 | 2.09 | 1.31 | 1.19 | 1.79 | 1.43 | - | 1.02 | 1.77 | 2.39 | 1.99 | 0.842 | 1.47 | 1.7 | 1.46 | 22.7 | 22.5 | 15.3 | 15.4 | 23 | 23 | 0.939 | 0.704 | 0.778 | 0.692 |
EV/EBITDA |
40.9 | - | 140 | 117 | 53.2 | 45.7 | 708 | 32.1 | -37.4 | -47.5 | -18.7 | -145 | -6.26 | 29.5 | -22.1 | 17.6 | - | -149 | -2.57 | -3.48 | 104 | 7.23 | 9.33 | 19.9 | 17.1 | 264 | 262 | 993 | 998 | -562 | -562 | 6.1 | 4.57 | 6.51 | 5.79 |
EV/OCF |
95.3 K | - | - | -179 | 76.6 | -27.2 | 64.2 | -19.9 | -18.7 | -9.37 | -11 | -7.4 | -15.1 | -18.5 | 8 | 87.4 | - | -6.39 | -2.52 | 26.5 | 47.6 | 21.8 | 5.21 | -18 | -15.4 | -201 | -200 | 1.25 K | 1.25 K | -599 | -598 | -11.4 | -8.5 | -17.5 | -15.6 |
Earnings Yield |
0.001 | - | 0.003 | -0.012 | 0.002 | -0.024 | -0.061 | -0.106 | -1.48 | -0.4 | -0.524 | -0.117 | -0.866 | 0.003 | -0.028 | 0.019 | - | -0.267 | -2.12 | -1.85 | 0.005 | - | - | -0.082 | -0.082 | -0.001 | -0.001 | -0.004 | -0.004 | -0.006 | -0.006 | 1.09 | 1.09 | 0.273 | 0.273 |
Free Cash Flow Yield |
0.0 | - | - | -0.01 | 0.016 | -0.071 | 0.005 | -0.12 | -0.341 | -0.422 | -0.246 | -0.307 | -0.207 | -0.143 | 0.218 | 0.02 | - | -1.15 | -1.63 | 0.102 | -0.031 | - | - | -0.204 | -0.204 | -0.006 | -0.006 | -0.0 | -0.0 | -0.004 | -0.004 | -2.37 | -2.37 | -1.09 | -1.09 |
Debt To Equity |
-4.99 | -5.05 | -4.71 | -4.46 | -8.72 | -1.95 | -1.72 | -2.1 | -1.5 | -2.1 | -2.33 | 1.02 K | -38.2 | 4.13 | 9.52 | 3.88 | -16.8 | -0.868 | -0.826 | -13.7 | 51 | 18.9 | 8.01 | 5.86 | 4.64 | 3.43 | 4.89 | 17 | 5.51 | 3.89 | 3.32 | 2.86 | 2.64 | 2.27 | 2.12 |
Debt To Assets |
0.776 | 0.744 | 0.828 | 0.906 | 0.913 | 1.41 | 1.24 | 1.16 | 1.69 | 1.06 | 0.806 | 0.589 | 0.453 | 0.352 | 0.484 | 0.365 | 0.383 | 2.76 | 2.03 | 0.546 | 0.491 | 0.437 | 0.438 | 0.674 | 0.558 | 0.433 | 0.345 | 0.258 | 0.314 | 0.364 | 0.412 | 0.482 | 0.471 | 0.449 | 0.458 |
Net Debt To EBITDA |
9.85 | - | 30.6 | 25.4 | 16.6 | 15.3 | 227 | 16.7 | -30.7 | -35.1 | -11.4 | -80.1 | -4.04 | 17 | -10.1 | 7.46 | - | -129 | -1.97 | -2.8 | 57.9 | 7.23 | 9.33 | 13.4 | 10.6 | 7.44 | 5.8 | 15.8 | 21.5 | -15.2 | -15 | 5.71 | 4.18 | 5.68 | 4.95 |
Current Ratio |
0.516 | 0.537 | 0.467 | 0.704 | 1.23 | 0.759 | 0.543 | 0.468 | 0.3 | 0.512 | 0.627 | 0.635 | 0.471 | 1.03 | 0.702 | 0.758 | 0.768 | 0.392 | 0.335 | 0.846 | 0.815 | 0.833 | 0.821 | 1.32 | 1.22 | 1.12 | 0.908 | 0.76 | 0.699 | 0.649 | 0.802 | 1.2 | 1.23 | 1.29 | 0.942 |
Interest Coverage |
- | - | - | - | 0.209 | 0.305 | -0.094 | -0.343 | - | - | - | - | - | - | - | - | - | - | -5.28 | -5.28 | - | 1.03 | - | 1.0 | 1.0 | 0.75 | 0.75 | -0.374 | -0.374 | -1.47 | -1.47 | 0.743 | 0.743 | 0.996 | 0.996 |
Income Quality |
16.4 | - | - | 0.589 | 1.47 | 2.27 | -0.379 | 0.987 | 0.204 | 1.02 | 0.445 | 2.58 | 0.216 | -44.1 | -6.85 | 0.779 | - | 4.28 | 0.449 | -0.879 | 0.237 | -0.82 | 4.64 | 48.2 | 48.2 | -15.3 | -15.3 | -0.589 | -0.589 | 0.331 | 0.331 | -1.27 | -1.27 | -1.63 | -1.63 |
Sales General And Administrative To Revenue |
0.009 | - | 0.601 | 0.013 | - | 0.003 | 0.188 | 0.008 | 0.025 | 0.011 | 0.314 | 0.356 | 0.004 | 0.005 | 0.012 | 0.006 | - | - | 0.026 | 0.026 | 0.356 | 0.35 | 0.338 | 0.351 | 0.351 | 0.35 | 0.35 | 0.335 | 0.335 | 0.36 | 0.36 | - | - | - | - |
Intangibles To Total Assets |
0.311 | 0.309 | 0.34 | 0.355 | 0.23 | 0.266 | 0.295 | 0.334 | 0.347 | 0.591 | 0.575 | 0.654 | 0.669 | 0.37 | 0.596 | 0.517 | 0.359 | 0.003 | 0.004 | 0.256 | 0.238 | 0.231 | 0.239 | 0.277 | 0.287 | 0.299 | 0.301 | 0.303 | 0.312 | 0.32 | 0.321 | 0.324 | 0.265 | 0.149 | 0.148 |
Capex To Operating Cash Flow |
0.276 | - | - | -0.442 | 0.18 | -0.288 | 0.769 | -0.144 | -0.133 | -0.03 | -0.056 | -0.016 | -0.105 | -0.115 | 0.05 | - | - | -0.01 | -0.038 | 0.47 | 1.66 | 1.69 | 0.28 | -0.203 | -0.203 | -0.088 | -0.088 | 1.09 | 1.09 | -1.22 | -1.22 | -0.711 | -0.711 | -1.44 | -1.44 |
Capex To Revenue |
0.0 | - | - | 0.016 | 0.029 | 0.059 | 0.059 | 0.026 | 0.021 | 0.008 | 0.01 | 0.004 | 0.009 | 0.007 | 0.011 | - | - | 0.002 | 0.026 | 0.042 | 0.069 | 0.065 | 0.079 | 0.019 | 0.019 | 0.01 | 0.01 | 0.013 | 0.013 | 0.047 | 0.047 | 0.059 | 0.059 | 0.064 | 0.064 |
Capex To Depreciation |
0.129 | - | - | 0.119 | 0.147 | 0.616 | 0.565 | 0.212 | 0.18 | 0.061 | 0.33 | 0.151 | 0.28 | 0.652 | 0.967 | - | - | 0.23 | -3.14 | 0.907 | 6.28 | 2.39 | 4.16 | 0.82 | 0.82 | 0.435 | 0.435 | 0.651 | 0.651 | 1.95 | 1.95 | 2.41 | 2.41 | 2.51 | 2.51 |
Stock Based Compensation To Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.001 | -0.001 | 0.003 | 0.003 | - | - | - | - |
Graham Number |
0.473 | - | 0.936 | 1.87 | 0.738 | 5.45 | 7.59 | 12.7 | 51.6 | 20.8 | 24.7 | 0.517 | 10.1 | 1.73 | 3.81 | 4.39 | - | 95.2 | 276 | 81 | 1.7 | - | - | 39.7 | 39.8 | 0.607 | 0.455 | 0.454 | 0.914 | 1.62 | 1.72 | 547 | 489 | 212 | 203 |
Return On Invested Capital, ROIC |
0.108 | - | -0.372 | 0.134 | 0.009 | 0.035 | -0.016 | -0.042 | -0.124 | -0.081 | -0.193 | -0.038 | -0.279 | 0.08 | -0.099 | 0.045 | - | 0.107 | 2.45 | -0.262 | -0.001 | 0.001 | 0.042 | 0.485 | 0.526 | 0.006 | 0.007 | -0.026 | -0.022 | -0.059 | -0.065 | 0.013 | 0.018 | 0.027 | 0.032 |
Return On Tangible Assets, ROTA |
0.003 | - | 0.014 | -0.058 | 0.006 | -0.091 | -0.221 | -0.169 | -0.817 | -0.361 | -0.626 | -0.159 | -0.632 | 0.001 | -0.04 | 0.019 | - | -0.115 | -1.24 | -0.314 | 0.002 | -0.024 | -0.029 | -0.034 | -0.036 | -0.015 | -0.015 | -0.069 | -0.065 | -0.11 | -0.13 | 0.05 | 0.061 | 0.02 | 0.023 |
Graham Net Net |
-5.83 | - | -4.7 | -4.56 | -7.59 | -8.01 | -7.29 | -15 | -27.2 | -20.9 | -19.8 | -16 | -37.7 | -25.4 | -23 | -22.3 | - | -129 | -103 | -112 | -63.6 | - | - | -91.3 | -74 | -1.39 | -1.35 | -1.31 | -1.82 | -2.34 | -1.81 | -695 | -510 | -325 | -286 |
Working Capital |
-12.6 B | -12.7 B | -15.4 B | -4.46 B | 5.76 B | -5.12 B | -12 B | -14 B | -25.7 B | -13.4 B | -9.37 B | -8.08 B | -14.8 B | 776 M | -3.93 B | -3.87 B | -5.59 B | -4.06 B | -5.29 B | -2.14 B | -2.93 B | -2.74 B | -2.83 B | 2.53 B | 1.74 B | 958 M | -895 M | -2.75 B | -3.78 B | -4.81 B | -1.87 B | 1.07 B | 924 M | 779 M | -165 M |
Tangible Asset Value |
-19.9 B | -19.9 B | -19.5 B | -19.2 B | -18.2 B | -35.5 B | -33.2 B | -29.6 B | -48.2 B | -41 B | -36.8 B | -29.4 B | -30.5 B | -12.8 B | -14.9 B | -11.7 B | -11.5 B | -11.1 B | -10.3 B | -2.94 B | -1.62 B | -1.36 B | -1.03 B | -378 M | -527 M | -677 M | -496 M | -316 M | -556 M | -797 M | -898 M | -1 B | -116 M | 768 M | 652 M |
Net Current Asset Value, NCAV |
-36 B | -35.3 B | -31 B | -30.8 B | -29.8 B | -45.5 B | -41.9 B | -39.6 B | -58.5 B | -42.2 B | -38 B | -30.9 B | -32.2 B | -14.8 B | -16.7 B | -13.5 B | -13.9 B | -11.9 B | -11.9 B | -7.75 B | -5.66 B | -5.07 B | -4.65 B | -3.45 B | -3.67 B | -3.89 B | -3.79 B | -3.69 B | -4.57 B | -5.45 B | -4.75 B | -4.06 B | -2.92 B | -1.78 B | -1.66 B |
Invested Capital |
16.1 B | 15.4 B | 8.38 B | 18.8 B | 29.5 B | 13.9 B | 6.15 B | 6.55 B | -4.47 B | 9.51 B | 14.3 B | 22.3 B | 16.2 B | 18.6 B | 13.4 B | 12.3 B | 7.69 B | -3.28 B | -4.31 B | 8.36 B | 6.14 B | 5.95 B | 5.69 B | 10.6 B | 9.85 B | 9.13 B | 7.48 B | 5.84 B | 6 B | 6.16 B | 7.39 B | 8.61 B | 6.44 B | 4.26 B | 2.96 B |
Average Receivables |
- | - | 3.74 B | 1.28 B | 1.15 B | 2.28 B | 1.94 B | 2.3 B | 3.5 B | 4.01 B | 4.31 B | 3.34 B | 8.28 B | 8.05 B | 1.84 B | 3.96 B | 2.96 B | 77 M | 2.21 B | 2.17 B | - | -2 M | - | 1.17 B | 3.52 B | 4.72 B | 4.78 B | 3.6 B | 1.2 B | 742 M | 2.23 B | 2.67 B | 2.08 B | 1.6 B | - |
Average Payables |
13.9 B | - | 9.16 B | 7.88 B | 8.37 B | 11.2 B | 12.1 B | 10.8 B | 11.9 B | 15.4 B | 16.9 B | 18.6 B | 22.2 B | 17 B | 11.6 B | 14.8 B | 10.2 B | 3.73 B | 5.21 B | 5.94 B | 6.41 B | 6.15 B | - | 3.44 B | 3.71 B | 4.4 B | 5.51 B | 5.78 B | 5.21 B | 4.44 B | 3.45 B | 2.59 B | 1.87 B | 1.34 B | - |
Average Inventory |
8.59 B | - | 6.08 B | 5.49 B | 6.49 B | 7.65 B | 7.34 B | 7.02 B | 7.21 B | 7.64 B | 7.77 B | 7.45 B | 8.73 B | 7.32 B | 5.34 B | 7.94 B | 5.51 B | 1.81 B | 2.43 B | 3.1 B | 3.5 B | 3.44 B | - | 3.87 B | 3.59 B | 3.42 B | 3.36 B | 3.56 B | 4.01 B | 3.93 B | 3.29 B | 2.59 B | 1.81 B | 1.28 B | - |
Days Sales Outstanding |
- | - | 19 | 11.1 | - | 7.82 | 8.1 | 6.94 | 12.2 | 16 | 14.1 | 18.3 | 8.01 | 57.5 | 9.13 | 11.6 | - | 0.651 | 1.16 | 65.7 | - | - | -0.061 | - | 20.7 | 40.1 | 40.6 | 28.2 | 14.1 | - | 12.9 | 37.2 | 29.7 | 37.1 | 29.8 |
Days Payables Outstanding |
58.1 | - | 62.5 | 50 | 74.2 | 37.3 | 60 | 53.8 | 62 | 65.2 | 81.7 | 87.8 | 103 | 126 | 82.7 | 102 | - | 34.7 | 89.4 | 121 | 89.7 | 97.5 | 156 | 49.8 | 53.8 | 54.1 | 69.9 | 54.2 | 49.1 | 60.9 | 48.7 | 56.6 | 42.8 | 51.3 | 39.6 |
Days Of Inventory On Hand |
38.4 | - | 37.6 | 37.5 | 48.1 | 33.3 | 32.9 | 36.8 | 37.9 | 39.1 | 34.6 | 43.9 | 33.9 | 56.7 | 32.1 | 53.2 | - | 17.7 | 41.8 | 56.3 | 51.8 | 50.6 | 95.9 | 60.3 | 56.1 | 48.7 | 47.8 | 29.7 | 33.8 | 52.4 | 44.6 | 57 | 42.2 | 48.5 | 38.5 |
Receivables Turnover |
- | - | 4.74 | 8.11 | - | 11.5 | 11.1 | 13 | 7.37 | 5.64 | 6.37 | 4.92 | 11.2 | 1.57 | 9.86 | 7.73 | - | 138 | 77.3 | 1.37 | - | - | -1.48 K | - | 4.34 | 2.24 | 2.22 | 3.2 | 6.39 | - | 6.99 | 2.42 | 3.03 | 2.43 | 3.02 |
Payables Turnover |
1.55 | - | 1.44 | 1.8 | 1.21 | 2.41 | 1.5 | 1.67 | 1.45 | 1.38 | 1.1 | 1.03 | 0.875 | 0.717 | 1.09 | 0.886 | - | 2.59 | 1.01 | 0.744 | 1 | 0.923 | 0.576 | 1.81 | 1.67 | 1.66 | 1.29 | 1.66 | 1.83 | 1.48 | 1.85 | 1.59 | 2.1 | 1.75 | 2.28 |
Inventory Turnover |
2.34 | - | 2.39 | 2.4 | 1.87 | 2.7 | 2.74 | 2.44 | 2.37 | 2.3 | 2.6 | 2.05 | 2.65 | 1.59 | 2.81 | 1.69 | - | 5.09 | 2.16 | 1.6 | 1.74 | 1.78 | 0.939 | 1.49 | 1.6 | 1.85 | 1.88 | 3.03 | 2.66 | 1.72 | 2.02 | 1.58 | 2.13 | 1.86 | 2.34 |
Return On Equity, ROE |
-0.013 | - | -0.051 | 0.185 | -0.043 | 0.092 | 0.216 | 0.204 | 0.474 | 0.292 | 0.768 | -95.4 | 17.7 | 0.009 | -0.315 | 0.096 | - | 0.036 | 0.502 | 5.84 | 0.178 | -0.796 | -0.403 | -0.215 | -0.214 | -0.083 | -0.147 | -3.17 | -0.784 | -0.8 | -0.711 | 0.202 | 0.252 | 0.084 | 0.092 |
Capex Per Share |
0.0 | - | - | 0.044 | 0.048 | 0.227 | 0.217 | 0.172 | 0.203 | 0.073 | 0.113 | 0.043 | 0.204 | 0.171 | 0.184 | - | - | 0.163 | 1.25 | 2.01 | 2.52 | - | - | 1.63 | 1.63 | 0.021 | 0.021 | 0.042 | 0.042 | 0.1 | 0.1 | 46.7 | 46.7 | 30.5 | 30.5 |
Alle Zahlen in RUB-Währung
Hauptarten der Finanzberichte Аптеки 36.6 APTKFinanzberichterstattung ist das wichtigste Instrument, mit dem Unternehmen Interessengruppen über ihre finanzielle Lage, Geschäftsergebnisse und Veränderungen in der Kapitalstruktur informieren. Sie ist gewissermaßen die „Sprache der Wirtschaft“, die von Investoren, Gläubigern, Steuerbehörden und anderen Akteuren des wirtschaftlichen Umfelds verstanden wird.
- Gewinn- und Verlustrechnung
Zeigt Erträge, Aufwendungen sowie den Gewinn oder Verlust für einen bestimmten Zeitraum. Sie ermöglicht die Bewertung der Rentabilität eines Unternehmens. - Bilanz
Stellt Vermögenswerte, Verbindlichkeiten und Eigenkapital eines Unternehmens zu einem bestimmten Stichtag dar. Sie ist eine Momentaufnahme dessen, was das Unternehmen besitzt und schuldet.
Vermögenswerte – alles, was dem Unternehmen gehört (Bargeld, Anlagen, Gebäude, Forderungen usw.).
Verbindlichkeiten – Schulden und andere externe Finanzierungsquellen.
Eigenkapital – eigenes Kapital der Eigentümer und einbehaltene Gewinne. - Kapitalflussrechnung
Zeigt, woher das Unternehmen Geld erhält und wie es dieses in drei Bereichen verwendet: operative, Investitions- und Finanzierungstätigkeit.
- IFRS – Internationale Rechnungslegungsstandards, relevant für börsennotierte und multinationale Unternehmen.
- GAAP – Allgemein anerkannte Rechnungslegungsgrundsätze in den USA.
- RAS – Russische Rechnungslegungsstandards, die im Inland angewendet werden.
Die Finanzberichterstattung Аптеки 36.6 spielt eine entscheidende Rolle für Investoren, da sie eine objektive Informationsquelle über den aktuellen Zustand eines Unternehmens darstellt. Anhand der Berichte lässt sich erkennen, ob ein Unternehmen wächst, stagniert oder Marktanteile verliert. Dadurch können Investoren frühzeitig vielversprechende oder risikobehaftete Anlagen identifizieren.
Darüber hinaus bilden Finanzdaten die Grundlage für Prognosen zukünftiger Erträge. Historische Entwicklungen bei Umsatz, Gewinn und Cashflows helfen, potenzielle Dividenden, Kurssteigerungen und das Gesamtrisiko einer Investition einzuschätzen.
Transparente und ehrliche Berichterstattung ist auch ein Zeichen für die Reife und Verantwortlichkeit eines Unternehmens. Eine solche Offenheit stärkt das Vertrauen der Investoren und erleichtert Investitionsentscheidungen – insbesondere beim Vergleich mehrerer Unternehmen.
Schließlich ermöglicht die Finanzberichterstattung eine fundierte vergleichende Analyse. Sie erlaubt es, Unternehmen hinsichtlich Rentabilität, Verschuldung, Marge und anderen wichtigen Kennzahlen gegenüberzustellen – was besonders wichtig bei der Auswahl optimaler Investitionsmöglichkeiten innerhalb einer Branche oder eines Marktsegments ist.
Finanzberichte anderer Aktien in der Pharmaeinzelhändler
| Name | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|
 |
Greenlane Holdings
GNLN
|
$ 2.08 | -1.42 % | $ 15.7 M |  USA |
 |
China Jo-Jo Drugstores, Inc.
CJJD
|
- | -5.59 % | $ 49.9 M |  China |
 |
BOQI International Medical
BIMI
|
- | 6.33 % | $ 5.86 M | China |
 |
Trxade Group
MEDS
|
- | 4.55 % | $ 5.8 M | USA |
 |
PetMed Express
PETS
|
$ 3.39 | -2.31 % | $ 69.8 M | USA |
 |
LifeMD
LFMD
|
$ 3.47 | -1.0 % | $ 118 M | USA |
 |
Rite Aid Corporation
RAD
|
- | - | $ 35.5 M | USA |
 |
111
YI
|
$ 2.89 | -6.17 % | $ 497 M | China |
 |
Walgreens Boots Alliance
WBA
|
- | - | $ 10.3 B | USA |